Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) announced today that its letter
of intent with Epic Production Technologies International Inc. relating to a
proposed business combination has been terminated. The proposed transaction was
initially announced by Bradmer on December 21, 2011 and trading of the common
shares of Bradmer has been halted since that date. It is anticipated that the
common shares of Bradmer will resume trading on the NEX Board of the TSX Venture
Exchange on or about June 14, 2012.


The directors and officers of Bradmer intend to seek out new opportunities
considered to be in the best interests of Bradmer and its shareholders.
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Bradmer Pharmaceuticals
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Bradmer Pharmaceuticals